Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast Cancer
2022 · Advanced Materials · 282 citations
https://doi.org/10.1002/adma.202109609
W
Wenjuan Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
2.0K
Citations
21
h-index
33
i10-index
Wenjuan Ma is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Advanced biosensing and bioanalysis techniques & RNA Interference and Gene Delivery. The author has an h-index of 21, co-authored 57 publications.
Papers by this author
worksThe BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
2023 · Cellular and Molecular Immunology · 59 citations
https://doi.org/10.1038/s41423-023-01112-y
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
2024 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-024-54710-3
Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway
2021 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-021-04042-7
Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China
2024 · BMC Infectious Diseases · 15 citations
https://doi.org/10.1186/s12879-024-10198-2
Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial
2025 · European Heart Journal · 5 citations
https://doi.org/10.1093/eurheartj/ehaf570
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat